🇺🇸 rhIL-11 in United States

13 US adverse-event reports

Marketing authorisation

FDA

  • Status: approved

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Oedema Peripheral — 3 reports (23.08%)
  2. Drug Toxicity — 2 reports (15.38%)
  3. Analgesia — 1 report (7.69%)
  4. Arthritis — 1 report (7.69%)
  5. Asthenia — 1 report (7.69%)
  6. Blood Creatinine Increased — 1 report (7.69%)
  7. Blood Urea Increased — 1 report (7.69%)
  8. Circulatory Collapse — 1 report (7.69%)
  9. Depressed Level Of Consciousness — 1 report (7.69%)
  10. Drug Interaction — 1 report (7.69%)

Source database →

rhIL-11 in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is rhIL-11 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for rhIL-11 in United States?

Wyeth is now a wholly owned subsidiary of Pfizer is the originator. The local marketing authorisation holder may differ — check the official source linked above.